United States Cancer Gene Therapy Market Report 2017

Name: United States Cancer Gene Therapy Market Report 2017
Brand: QYResearch
SKU: UE63046D1C9EN
Price: 3800 USD
Availability: InStock

December 2017 | 119 pages | ID: UE63046D1C9EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Cancer Gene Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Cancer Gene Therapy in these regions, from 2012 to 2022 (forecast).

United States Cancer Gene Therapy market competition by top manufacturers/players, with Cancer Gene Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Adaptimmune
GlaxoSmithKline
Bluebird bio
Merck
Celgene
Shanghai Sunway Biotech
BioCancell
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
OncoGenex Pharmaceuticals
Genelux Corporation
Cell Genesys
Advantagene
GenVec
BioCancell
Celgene
Epeius Biotechnologies
Introgen Therapeutics
Ziopharm Oncology
Shenzhen SiBiono GeneTech
Altor Bioscience

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals
Diagnostics Centers
Research Institutes

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Cancer Gene Therapy Market Report 2017

1 CANCER GENE THERAPY OVERVIEW

1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Classification of Cancer Gene Therapy by Product Category
  1.2.1 United States Cancer Gene Therapy Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cancer Gene Therapy Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Gene Induced Immunotherapy
  1.2.4 Oncolytic Virotherapy
  1.2.5 Gene Transfer
1.3 United States Cancer Gene Therapy Market by Application/End Users
  1.3.1 United States Cancer Gene Therapy Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Diagnostics Centers
  1.3.4 Research Institutes
1.4 United States Cancer Gene Therapy Market by Region
  1.4.1 United States Cancer Gene Therapy Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.3 Southwest Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.5 New England Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.6 The South Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.7 The Midwest Cancer Gene Therapy Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cancer Gene Therapy (2012-2022)
  1.5.1 United States Cancer Gene Therapy Sales and Growth Rate (2012-2022)
  1.5.2 United States Cancer Gene Therapy Revenue and Growth Rate (2012-2022)

2 UNITED STATES CANCER GENE THERAPY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cancer Gene Therapy Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cancer Gene Therapy Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cancer Gene Therapy Average Price by Players/Suppliers (2012-2017)
2.4 United States Cancer Gene Therapy Market Competitive Situation and Trends
  2.4.1 United States Cancer Gene Therapy Market Concentration Rate
  2.4.2 United States Cancer Gene Therapy Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cancer Gene Therapy Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CANCER GENE THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cancer Gene Therapy Sales and Market Share by Region (2012-2017)
3.2 United States Cancer Gene Therapy Revenue and Market Share by Region (2012-2017)
3.3 United States Cancer Gene Therapy Price by Region (2012-2017)

4 UNITED STATES CANCER GENE THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cancer Gene Therapy Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cancer Gene Therapy Revenue and Market Share by Type (2012-2017)
4.3 United States Cancer Gene Therapy Price by Type (2012-2017)
4.4 United States Cancer Gene Therapy Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CANCER GENE THERAPY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cancer Gene Therapy Sales and Market Share by Application (2012-2017)
5.2 United States Cancer Gene Therapy Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CANCER GENE THERAPY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Adaptimmune
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cancer Gene Therapy Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Adaptimmune Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline
  6.2.2 Cancer Gene Therapy Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bluebird bio
  6.3.2 Cancer Gene Therapy Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bluebird bio Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.2 Cancer Gene Therapy Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Celgene
  6.5.2 Cancer Gene Therapy Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Celgene Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Shanghai Sunway Biotech
  6.6.2 Cancer Gene Therapy Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Shanghai Sunway Biotech Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 BioCancell
  6.7.2 Cancer Gene Therapy Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BioCancell Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Shenzhen SiBiono GeneTech
  6.8.2 Cancer Gene Therapy Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 SynerGene Therapeutics
  6.9.2 Cancer Gene Therapy Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 SynerGene Therapeutics Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 OncoGenex Pharmaceuticals
  6.10.2 Cancer Gene Therapy Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Genelux Corporation
6.12 Cell Genesys
6.13 Advantagene
6.14 GenVec
6.15 BioCancell
6.16 Celgene
6.17 Epeius Biotechnologies
6.18 Introgen Therapeutics
6.19 Ziopharm Oncology
6.20 Shenzhen SiBiono GeneTech
6.21 Altor Bioscience

7 CANCER GENE THERAPY MANUFACTURING COST ANALYSIS

7.1 Cancer Gene Therapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Gene Therapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cancer Gene Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CANCER GENE THERAPY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cancer Gene Therapy Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cancer Gene Therapy Sales Volume Forecast by Type (2017-2022)
11.3 United States Cancer Gene Therapy Sales Volume Forecast by Application (2017-2022)
11.4 United States Cancer Gene Therapy Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Cancer Gene Therapy
Figure United States Cancer Gene Therapy Market Size (Units) by Type (2012-2022)
Figure United States Cancer Gene Therapy Sales Volume Market Share by Type (Product Category) in 2016
Figure Gene Induced Immunotherapy Product Picture
Figure Oncolytic Virotherapy Product Picture
Figure Gene Transfer Product Picture
Figure United States Cancer Gene Therapy Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Cancer Gene Therapy by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Diagnostics Centers Examples
Table Key Downstream Customer in Diagnostics Centers
Figure Research Institutes Examples
Table Key Downstream Customer in Research Institutes
Figure United States Cancer Gene Therapy Market Size (Million USD) by Region (2012-2022)
Figure The West Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2022)
Figure United States Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cancer Gene Therapy Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Cancer Gene Therapy Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Cancer Gene Therapy Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cancer Gene Therapy Sales Share by Players/Suppliers
Figure 2017 United States Cancer Gene Therapy Sales Share by Players/Suppliers
Figure United States Cancer Gene Therapy Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cancer Gene Therapy Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cancer Gene Therapy Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cancer Gene Therapy Revenue Share by Players/Suppliers
Figure 2017 United States Cancer Gene Therapy Revenue Share by Players/Suppliers
Table United States Market Cancer Gene Therapy Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cancer Gene Therapy Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cancer Gene Therapy Market Share of Top 3 Players/Suppliers
Figure United States Cancer Gene Therapy Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cancer Gene Therapy Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cancer Gene Therapy Product Category
Table United States Cancer Gene Therapy Sales (Units) by Region (2012-2017)
Table United States Cancer Gene Therapy Sales Share by Region (2012-2017)
Figure United States Cancer Gene Therapy Sales Share by Region (2012-2017)
Figure United States Cancer Gene Therapy Sales Market Share by Region in 2016
Table United States Cancer Gene Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cancer Gene Therapy Revenue Share by Region (2012-2017)
Figure United States Cancer Gene Therapy Revenue Market Share by Region (2012-2017)
Figure United States Cancer Gene Therapy Revenue Market Share by Region in 2016
Table United States Cancer Gene Therapy Price (K USD/Unit) by Region (2012-2017)
Table United States Cancer Gene Therapy Sales (Units) by Type (2012-2017)
Table United States Cancer Gene Therapy Sales Share by Type (2012-2017)
Figure United States Cancer Gene Therapy Sales Share by Type (2012-2017)
Figure United States Cancer Gene Therapy Sales Market Share by Type in 2016
Table United States Cancer Gene Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cancer Gene Therapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Gene Therapy by Type (2012-2017)
Figure Revenue Market Share of Cancer Gene Therapy by Type in 2016
Table United States Cancer Gene Therapy Price (K USD/Unit) by Types (2012-2017)
Figure United States Cancer Gene Therapy Sales Growth Rate by Type (2012-2017)
Table United States Cancer Gene Therapy Sales (Units) by Application (2012-2017)
Table United States Cancer Gene Therapy Sales Market Share by Application (2012-2017)
Figure United States Cancer Gene Therapy Sales Market Share by Application (2012-2017)
Figure United States Cancer Gene Therapy Sales Market Share by Application in 2016
Table United States Cancer Gene Therapy Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Gene Therapy Sales Growth Rate by Application (2012-2017)
Table Adaptimmune Basic Information List
Table Adaptimmune Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table Bluebird bio Basic Information List
Table Bluebird bio Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Merck Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure Merck Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table Celgene Basic Information List
Table Celgene Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Celgene Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure Celgene Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table Shanghai Sunway Biotech Basic Information List
Table Shanghai Sunway Biotech Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table BioCancell Basic Information List
Table BioCancell Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure BioCancell Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure BioCancell Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure BioCancell Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table Shenzhen SiBiono GeneTech Basic Information List
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table SynerGene Therapeutics Basic Information List
Table SynerGene Therapeutics Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table OncoGenex Pharmaceuticals Basic Information List
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Sales Market Share in United States (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Market Share in United States (2012-2017)
Table Genelux Corporation Basic Information List
Table Cell Genesys Basic Information List
Table Advantagene Basic Information List
Table GenVec Basic Information List
Table BioCancell Basic Information List
Table Celgene Basic Information List
Table Epeius Biotechnologies Basic Information List
Table Introgen Therapeutics Basic Information List
Table Ziopharm Oncology Basic Information List
Table Shenzhen SiBiono GeneTech Basic Information List
Table Altor Bioscience Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Gene Therapy
Figure Manufacturing Process Analysis of Cancer Gene Therapy
Figure Cancer Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Gene Therapy Major Players/Suppliers in 2016
Table Major Buyers of Cancer Gene Therapy
Table Distributors/Traders List
Figure United States Cancer Gene Therapy Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cancer Gene Therapy Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Cancer Gene Therapy Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Cancer Gene Therapy Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Cancer Gene Therapy Sales Volume (Units) Forecast by Type in 2022
Table United States Cancer Gene Therapy Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Cancer Gene Therapy Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Cancer Gene Therapy Sales Volume (Units) Forecast by Application in 2022
Table United States Cancer Gene Therapy Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Cancer Gene Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cancer Gene Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cancer Gene Therapy Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Cancer Gene Therapy Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports